Second Genome Company
Second Genome offers a pipeline of microbiome modulators that impact infection, immunity and metabolic diseases.
Technology:
Anti-infective Drugs
Industry:
PharmTech
Headquarters:
San Francisco, California, United States
Founded Date:
2009
Employees Number:
11-50
Funding Status:
Early Stage Venture
Estimated Revenue:
$1M to $10M
Register and Claim Ownership